Skip to content
The Kids Research Institute Australia logo

Search

SJ-ELiOT: St Jude - Phase 1 Evaluation of LY2606368, Molecularly-Targeted CHK1/2i Therapy, in Combination with Cyclophosphamide or Gemcitabine for Children and Adolescents with Refractory or Recurrent Medulloblastoma Brain Tumours

Sensitising glioblastoma to enhance cancer therapy

Radiosensitisation of medulloblastoma

Exploring the immune microenvironment and investigating novel immunotherapeutics for medulloblastoma and paediatric high-grade glioma

Chemosensitisation of medulloblastoma and pineoblastoma

An initial health economic evaluation of the potential benefits gained by reducing late effects in paediatric brain cancer survivors

CONNECT – Collaborative Network for Neuro-oncology Clinical Trials

The Kids Cancer Biobank, patient-derived xenograft model development and genome-wide characterization

Stephanie Trend

Honorary Research Associate

Findings from the LiLO study

Learn about the findings from the LiLo study.